Psychedelic Therapy Could Help Millions

Get With the Program, Docs: Here’s Why

5 million Americans walk into a doctor’s office.

No, that’s not the setup for a bad joke. Unless, of course, you consider our healthcare system a joke. Which... well... ahem let's not go there.

But this number is no laughing matter. It's the potential future of psychedelic therapy in the U.S. According to a recent study, at least 5 million Americans could benefit from treatment with psilocybin, the active compound in magic mushrooms. And as research keeps expanding, this number could get even bigger. Let’s run the numbers:

• 15 million: The number of American adults with depression, based on a national survey.

• 9 million: The subset of those adults who actually get treatment in a given year.

• 5.1-5.6 million: The subset of adults in treatment who meet the eligibility criteria from recent clinical trials of psilocybin therapy.

That’s enough people to fill more than 70 football stadiums.

And this is likely just the tip of the iceberg. Think of all the untreated folks who could be drawn to psychedelics as an alternative to traditional therapies that don’t work for them.

Now, here's where the story takes a tragic turn: even though millions of people could benefit, the conversation about psychedelics in healthcare is still stifled. A separate study out of Canada sheds light on why this happens.

Out of 800 adults surveyed:

• 33% had discussed their use of psychedelics with their doctor.

• 60% were dissatisfied with the conversation.

• Over 50% felt judged or discriminated against for even bringing up the topic.

Stigma, knowledge gaps, and plain old awkwardness seem to be the main reasons why the conversation around psychedelics is often a non-starter. And that’s in Canada, where doctors can legally prescribe psychedelics if they’re willing to navigate some red tape.

Here in the U.S., things are even murkier. While there’s growing excitement in the world of psychedelic science, the medical establishment is dragging its feet, leaving patients caught in a frustrating limbo. Imagine trying to explain to your doctor that you’re interested in a therapy that isn’t yet mainstream, and instead of support, you’re met with skepticism, or worse—disapproval.

So, where does this leave us?

The data is clear: millions of Americans stand to gain from psychedelic therapy. But until we close the gap between groundbreaking research and real-world acceptance, the only trip worth stressing over is the one to your doctor's office.

In the meantime, for those of you feeling frustrated by the barriers to accessing new treatments, know this: progress is happening, even if it’s slow.

Advocacy, education, and more open dialogue will continue to push the needle forward. Psychedelic therapy may one day become as routine as talking about cholesterol levels—if we keep pushing to break down the stigma and bring science to the forefront of patient care.

Stay tuned as we continue to monitor the growing world of psychedelic medicine and how it could reshape the future of mental health care.

Share it

Thanks always for taking the time to read this.

If you’ve enjoyed this volume of The Movement, please spread the love and tell your friends! You can share this newsletter using the link below:

https://the-movement.beehiiv.com/subscribe

Do you have any suggestions for The Movement? Reply directly to this email or shoot me a message on Instagram.

See yah out there,

Ryan